Dissolution Testing Flunks FDA Advisory Committee Exam As Development Tool
Executive Summary
The difficulties in adapting in vitro dissolution tests to use in drug development are that they tend to be individual for a drug and dosage form and that they replicate only one portion of in vivo activity, members of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology tell FDA.